Perficient: Drug Development

OCTOBER 9, 2024

IDC Market Glance: Digital Business Professional Services, 3Q24 Perficient is thrilled to be included in the Technology Transformation Dominant consultancy category in the latest IDC Market Glance: Digital Business Professional Services report (doc #US51480824, September 2024).

Marketing 104

Marketing 104

Drug Patent Watch

OCTOBER 10, 2024

China has emerged as a significant player in the global generic drug active pharmaceutical ingredient (API) market. This article will delve into the role of China in the global generic drug API market, exploring its market share… Source

Marketing 102

Marketing Pharmaceutical Companies Drugs Pharmaceuticals 102

Science Daily: Pharmacology News

SEPTEMBER 19, 2024

A new study provides a list of the wildlife species present at the market from which SARS-CoV-2, the virus responsible for the COVID-19 pandemic, most likely arose in late 2019. The study is based on a new analysis of metatranscriptomic data released by the Chinese Center for Disease Control and Prevention (CDC).

Marketing 132

Marketing Virus Disease 132

Drugs.com

SEPTEMBER 19, 2024

19, 2024 -- The Hunan Seafood Wholesale wet market in Wuhan, China, has long been considered the most likely source of the coronavirus that caused the COVID-19 pandemic. THURSDAY, Sept. That theory is now supported by a new study analyzing more.

Marketing 105

Marketing 105

Common Sense for Drug Policy Blog

NOVEMBER 15, 2024

Misrepresentation of Drugs in the Unregulated Market "The misrepresentation of illicit drugs is a persistent problem in unregulated markets ( Barratt et al., 2024 , Marshman and Gibbins, 1969 ).

Marketing 52

Marketing Drugs 52

Drug Patent Watch

SEPTEMBER 23, 2024

The generic drug market has experienced significant growth over the past few decades, driven by the expiration of patents on branded drugs and the increasing demand for affordable healthcare solutions. To succeed in this market, generic drug manufacturers must adopt innovative… Source

Marketing 88

Marketing Drugs 88

Drug Channels

NOVEMBER 15, 2024

The authors outline the challenges that manufacturers face when integrating internal and external datasets to build market access and commercialization strategies. TThey argue that unified datasets and the addition of AI-driven analytics tools can improve decision making throughout a drug’s life cycle.

Marketing 79

Marketing International Drugs 79

Drug Channels

NOVEMBER 13, 2024

As I predicted, the stand-alone Medicare Part D prescription drug plans (PDP) market is vanishing. The destruction of the Part D market marks yet another unintended consequence of the Inflation Reduction Act of 2022 (IRA). Legislate in haste. Repent in leisure. What else should you expect for 2025? to 1:30 p.m.

Pharmacy 86

Pharmacy Marketing Drugs 86

Fierce BioTech

OCTOBER 21, 2024

Chiefly, Sailer highlights the transformative impact of AI and machine learning in drug development, a trend which, he believes, can potentially double approval rates while reducing costs and time-to-market.

Marketing 98

Marketing Clinical Development Drug Development Drugs 98

Perficient: Drug Development

APRIL 16, 2024

IDC Market Glance: Payer, 2Q24 Perficient is excited to be included in the IDC Market Glance: Payer, 2Q24 (doc #US51961724, April 2024) report. According to IDC, this report “provides a glance at the current makeup of the payer IT landscape, illustrates the vendor landscape, and depicts the segments and structure of the market.”

Marketing 107

Marketing Government 107

Common Sense for Drug Policy Blog

NOVEMBER 15, 2024

Adulteration of MDMA in the Unregulated Market "Most of the concern with MDMA adulteration focuses on the plethora of other substances that have been detected in the MDMA supply. Piperazines first appeared in 2000 but saturated the market from 2008–2013, when these compounds were detected in about one-quarter (24 %) of drug items.

Marketing 52

Marketing Pharmaceuticals Drugs 52

ProRelix Research

NOVEMBER 2, 2023

Limited patient populations, […] The post Post-Marketing Surveillance Strategies appeared first on ProRelix Research. Although clinical trials provide useful information regarding the efficacy and safety of new drugs, biological products, and medical devices, the information captured through them is not all-encompassing.

Marketing 98

Marketing Clinical Trials Trials Production 98

Alta Sciences

NOVEMBER 5, 2024

And when it’s time to go to market, the scale-up of the manufacturing process for commercialization is straightforward. Because of these qualities, liquid-filled hard capsules offer a great opportunity for line extensions, and brand differentiation, in the competitive pharma market. Why Liquid-Filled, Hard-Shell Capsules?

Marketing 52

Marketing Small Molecule Production Pharmaceuticals 52

Perficient: Drug Development

OCTOBER 22, 2024

A prominent labor union representing a large number of educators in a major metropolitan public school system recognized this need and partnered with Perficient to implement a scalable Salesforce Marketing Cloud Personalization solution. What is Marketing Cloud Personalization? The team was amazing from start to finish.

Marketing 52

Marketing Nurses Licensing Licensing 52

Drug Patent Watch

JULY 25, 2024

The generic drug market has been significantly impacted by the COVID-19 pandemic, with both challenges and opportunities arising from the crisis. As the world continues to recover…

Marketing 96

Marketing Drugs 96

Perficient: Drug Development

SEPTEMBER 6, 2024

Salesforce’s position as a leader in this report reflects its current offerings, robust strategy, and strong market influence. Strategy: Forrester evaluates the vendor’s long-term vision, innovation roadmap, and ability to address future market needs.

Marketing 59

Marketing Compliance Production Engineering 59

Perficient: Drug Development

SEPTEMBER 3, 2024

The world of Digital Marketing is challenging and always updating with new strategies. Gen AI can pump up your digital marketing efforts by creating highly engaged SEO-friendly content and boost your brand on SERP (Search Engine Result Page). What is Generative AI, and How Does it Work?

Marketing 52

Marketing Production Engineering Research 52

Drugs.com

APRIL 4, 2024

THURSDAY, April 4, 2024 (HealthDayNews) -- Following disappointing trial results, the maker of a controversial ALS drug said it is pulling the medication off the market. In a statement issued Thursday, Amylyx Pharmaceuticals said that Relyvrio.

Marketing 111

Marketing Drugs Pharmaceuticals Trials 111

Perficient: Drug Development

OCTOBER 28, 2024

IDC Market Glance: Digital Business Professional Services, 3Q24 Perficient is thrilled to be included in the Technology Transformation Dominant consultancy category in the latest IDC Market Glance: Digital Business Professional Services report (doc #US51480824, September 2024).

Marketing 52

Marketing 52

Perficient: Drug Development

OCTOBER 8, 2024

One shining example is our recruitment strategy for Bayhealth, which was recently featured by the online publication, Strategic Health Care Marketing. Recognizing the need for a unified front, our team emphasized the importance of collaboration between HR and marketing.

Marketing 52

Marketing Testimonials Hospitals Science 52

Fierce BioTech

AUGUST 7, 2024

The Unfiltered Truth about AI & Pharma Marketing dwunderlin Wed, 08/07/2024 - 12:04 Wed, 09/04/2024 - 14:00 Resource Type Webinar Chris Cullmann Doug Barr Promotion Start Thu, 08/08/2024 - 15:00 Promotion End Sat, 02/08/2025 - 15:00 Duration 60 Minutes You need to know where artificial intelligence disrupts the pharmaceutical marketing norms.

Marketing 52

Marketing Pharmaceutical Companies Pharmaceuticals Production 52

Collaborative Drug

APRIL 19, 2024

Tokyo, Japan, April 17, 2024 — In a significant move to bolster CDD Vault’s presence in the Japanese market, Collaborative Drug Discovery (CDD) is excited to announce the appointment of Mr. Yasushi Hamagashira as the new Head of Sales and Marketing for Japan.

Marketing 106

Marketing Drugs 106

Fierce BioTech

MARCH 15, 2024

Oncology Market Outlook 2024 This paper assesses the current state of the oncology market, reviewing key expectations for 2024. jpiatt Fri, 03/15/2024 - 13:46 This paper assesses the current state of the oncology market, reviewing key expectations for 2024.

Targeted Protein Degradation 52

Targeted Protein Degradation Marketing Therapies Science 52

Drug Patent Watch

JULY 1, 2024

Lipitor’s marketing strategy underwent a significant evolution as generic competition emerged, employing aggressive tactics to retain market share and brand […] Source

Marketing 89

Marketing Pharmaceuticals 89

Fierce BioTech

FEBRUARY 21, 2024

CNS Market Outlook, 2024 This paper assesses the current state of the broad CNS market, reviewing key expectations for 2024. It also provides a high-level look at the pain market and the evolving regulatory environment. It addresses Alzheimer’s disease, biomarkers, and advances in psychiatry in detail.

Marketing 52

Marketing Science Disease 52

Perficient: Drug Development

OCTOBER 9, 2024

, Jim talks with Scott Brinker , VP of Platform Ecosystems at HubSpot and editor of the pioneering blog chiefmartec.com , about the evolving world of marketing technology (MarTech) and how marketers can stay ahead. Marketers now juggle a mix of platforms, from CMS and email marketing to LinkedIn and Generative AI.

Marketing 52

Marketing Production 52

Fierce BioTech

AUGUST 21, 2024

Market-Moving Trends to Watch in H2 2024 In a market defined by unpredictability, volatility, and fast-paced evolution, it can be challenging to determine where it’s heading and what executives should concern themselves with in the second half of 2024 and beyond. Interest in obesity drugs has led to billions of new prescriptions.

Marketing 52

Marketing Drugs 52

Cytel

MAY 7, 2024

Here we explore the evolution and impact of market exclusivity policies in the EU and US, highlighting their role in fostering innovation and accessibility in rare disease treatment. Market exclusivity for orphan drugs traces back to the early 1980s in the United States, with the landmark Orphan Drug Act of 1983.

Marketing 59

Marketing Production Drugs Disease 59

Drugs.com

MARCH 11, 2024

MONDAY, March 11, 2024 -- Following disappointing trial results, the maker of a controversial ALS drug may pull the medication off the market. In a statement issued Friday, Amylyx Pharmaceuticals said that Relyvrio failed to help patients in a.

Marketing 115

Marketing Trials Drugs Pharmaceuticals 115

Perficient: Drug Development

JANUARY 16, 2024

Personalization (formerly known as Interaction Studio) is a tool that exists inside the Salesforce Marketing Cloud tenant. In this case, we want to know where the user is for marketing and statistical purposes, and not punish our user in the same way Lotso wants to catch the toys. The sitemap is the heart of personalization.

Marketing 64

Marketing Production 64

Perficient: Drug Development

JULY 11, 2024

Now, as part of the latest release, Salesforce have released Marketing Cloud Engagement link shortener. Marketing Cloud Engagement link shortener is enabled only for Hyperforce users for now. For this, you would have used bitly in the past. This utilizes AWS to shorten the URLs. References: [link]

Marketing 52

Marketing 52

Drug Channels

NOVEMBER 19, 2024

In Medicare Part D in 2025: Preferred Pharmacy Networks Fade in a Collapsing PDP Market , I documented the Inflation Reduction Act’s (IRA) disruption to Medicare Part D prescription drug plans (PDPs). As always, we provide you with a handy table for tallying each chain’s participation and changes from 2024 to 2025.

Pharmacy 66

Pharmacy Marketing Drugs 66

BioPharma Drive: Drug Pricing

OCTOBER 23, 2023

Effective marketing measurement requires objectivity, connected data, transparency, a track record of innovation and a proven ability to execute.

Marketing 107

Marketing 107

Fierce BioTech

JUNE 18, 2024

Experts recommend that CGT manufacturers proactively design a comprehensive market access strategy early in clinical development and commercial planning timelines, ideally more than three years pri | CGT companies should consider developing a market access strategy early in clinical development, ideally more than three years prior to launch.

Marketing 75

Marketing Clinical Development 75

Fierce BioTech

OCTOBER 15, 2024

A Pharma Marketers' Roadmap to Data Privacy Compliance : Are You Ready for 2025? swheeler Tue, 10/15/2024 - 19:53 Thu, 11/21/2024 - 13:00 Resource Type Webinar Ben Chapman Duration 60 minutes Join for an insightful webinar on the evolving privacy landscape impacting pharma marketers in 2025.

Compliance 52

Compliance Marketing Regulations 52

Perficient: Drug Development

SEPTEMBER 6, 2024

IDC Market Glance: Customer Experience Services, 3Q24 Perficient is excited to announce that we have been included in the IDC Market Glance: Customer Experience Services, 3Q24, doc # US51521224, August 2024 report.

Marketing 52

Marketing Science 52

Fierce BioTech

SEPTEMBER 24, 2024

Unlocking European market access for rare disease therapies The European orphan drug market presents a significant opportunity for biotech firms. Learn more about early access programs (EAPs), and how they are emerging as a critical strategy for successfully launching rare disease therapies in this complex and diverse market.

Marketing 40

Marketing Therapies Disease Drugs 40